Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

0.7954
Delayed Data
As of Oct 20
 -0.0046 / -0.58%
Today’s Change
0.76
Today|||52-Week Range
1.47
-30.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$84.2M

Company Description

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. Its products include Qsymia and STENDRA/SPEDRA. The company was founded by Virgil A. Palace in April 16, 1991 and is headquartered in Mountain View, CA.

Contact Information

VIVUS, Inc.
900 East Evelyn Avenue
Campbell California 95008
P:(650) 934-5200
Investor Relations:

Employees

Shareholders

Mutual fund holders5.95%
Other institutional31.09%
Individual stakeholders24.29%

Top Executives

Seth H. Z. FischerChief Executive Officer & Director
Mark K. OkiChief Financial & Accounting Officer
Santosh T. VargheseChief Medical Officer
Ted BromanVice President-Chemistry, Manufacturing & Control
Sandra E. WellsVice President-Patents & Assistant General Counsel